| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.7M | +0.8% |
| SG&A Expense | $1.7M | -12.4% |
| Operating Income | -$3.4M | +6.3% |
| Net Income | -$3.3M | +1.2% |
| EPS (Basic) | -$0.02 | +0.0% |
| EPS (Diluted) | -$0.02 | +0.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.4M | -57.6% |
| Current Assets | $2.4M | -57.0% |
| Total Assets | $2.5M | -55.9% |
| Current Liabilities | $766K | +8.0% |
| Long-term Debt | $37K | — |
| Total Liabilities | $3.8M | +2.5% |
| Stockholders' Equity | -$1.3M | -165.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.2M | +0.1% |